The Greatest Story Never Told
The U.S. Food and Drug Administration (FDA) has approved four vaccines for use against the 2009 H1N1 influenza virus. The vaccines—made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and sanofi pasteur Inc.—will be distributed nationally after the initial lots become available. This is expected to occur within the next four weeks.
Jeffry John Aufderheide
VacTRUTH
09/11/09
(*** EDITORS NOTE: THIS JUST IN, FDA APPROVES SWINE VACCINE PRIOR TO CHILDREN SAFETY STUDY BEGINNING!!!! SEE ARTICLE HERE. )
See for yourself the study presented at the end of article. Please spread the word and make this go viral… no pun intended. Kindly reference and link to VacTRUTH!
(vactruth.com) Trials for the experimental H1N1 Swine flu vaccine commence Tuesday, September 15th in Thornton, Colorado. Novartis, a bio-pharmaceutical company that manufactures the vaccine, is recommending that children participating in the trial receive two doses of an experimental vaccine which contain ingredients found in spermicides, cleaners, and cosmetics along with thimerosal and squalene (MF59). Everyone should have a sense of concern as the only safety checks for these children are a few blood draws and follow-up phone calls. No neurological testing. No kidding.
he U.S. Food and Drug Administration (FDA) today announced that it has approved a new manufacturing facility used to produce influenza virus vaccines. The facility is approved for seasonal influenza vaccine production and could be used for the production of vaccine against the new 2009 H1N1 influenza strain. As part of its overall pandemic influenza preparedness efforts, the FDA meets with vaccine manufacturers to guide the efficient establishment of influenza vaccine facilities that comply with agency requirements. The agency promptly reviews applications and manufacturing supplements that could increase both the number of manufacturers and the overall supply of vaccine.
Follow Us!